© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 17, 1440-1441,
September 1, 1999
© 1999 Oxford University Press
EDITORIALS |
Human Herpesvirus 8 and Cancer
Affiliations of authors: V. Beral, R. Newton, Cancer Epidemiology Unit, University of Oxford, Imperial Cancer Research Fund, Oxford, U.K.; F. Sitas, Cancer Epidemiology Unit, National Cancer Registry, South African Institute for Medical Research, Johannesburg.
Correspondence to: Valerie Beral, M.D., Cancer Epidemiology Unit, University of Oxford, Imperial Cancer Research Fund, Gibson Bldg., The Radcliffe Infirmary, Oxford OX2 6HE, U.K.
In 1994, Chang, Moore, and colleagues (1) reported that
they had discovered DNA sequences of a new herpesvirus in Kaposi's
sarcoma tumor tissue. The new virus, known as Kaposi's sarcoma
herpesvirus or human herpesvirus 8 (HHV8), is now widely believed to be
a necessary cause of Kaposi's sarcoma [(2); reviewed in
(3)]. The prevalence of antibodies against HHV8 varies
substantially across populations, and there is a close association
worldwide between seroprevalence rates of anti-HHV8 antibodies and the
incidence of Kaposi's sarcoma. Kaposi's sarcoma is extremely rare in
REFERENCES
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Plancoulaine, L. Abel, M. van Beveren, and A. Gessain High Titers of Anti-Human Herpesvirus 8 Antibodies in Elderly Males in an Endemic Population J Natl Cancer Inst, September 4, 2002; 94(17): 1333 - 1335. [Abstract] [Full Text] [PDF] |
||||
